First Record of Leea guineensis (Vitaceae) in Cuban Scientific Literature

The presence of Leea guineensis G. Don. was confirmed in Cuba. It is a widely cultivated alochtonous species used in Cuba as ornameltal plants, which had not been previously registered in the scientific literature of the country. Several botanical procedures (collections, specialized catalogs, descriptions, and scientific illustrations) were applied. It is a new taxon of the genus in the country. A key is suggested as a way to distinguish it from other genera of the Vitaceae family

Primer registro Leea guineensis (Vitaceae) en la literatura especializada cubana

Se confirma la presencia en Cuba de Leea guineensis G. Don., especie alóctona ampliamente cultivada con fines ornamentales, que no estaba registrada anteriormente por la literatura científica del país. Se emplearon métodos propios de la botánica, como el trabajo con colecciones, el uso de catálogos especializados, la descripción e ilustración científica. Dado que es un nuevo taxón de ese género en la nación. Se ofrece una clave para diferenciarlo de los restantes géneros pertenecientes a la familia Vitaceae

First Record of Leea guineensis (Vitaceae) in Cuban Scientific Literature

The presence of Leea guineensis G. Don. was confirmed in Cuba. It is a widely cultivated alochtonous species used in Cuba as ornameltal plants, which had not been previously registered in the scientific literature of the country. Several botanical procedures (collections, specialized catalogs, descriptions, and scientific illustrations) were applied. It is a new taxon of the genus in the country. A key is suggested as a way to distinguish it from other genera of the Vitaceae family

Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer's Disease Therapy

In this communication, wereport the synthesis and cholinesterase (ChE)/monoamine oxidase (MAO) inhibition of 19 quinolinones (QN1-19) and 13 dihydroquinolinones (DQN1-13) designed as potential multitarget small molecules (MSM) for Alzheimer¿s disease therapy. Contrary to our expectations, none of them showed significant human recombinant MAO inhibition, but compounds QN8, QN9, and DQN7 displayed promising human recombinant acetylcholinesterase (hrAChE) and butyrylcholinesterase (hrBuChE) inhibition. In particular, molecule QN8 was found to be a potent and quite selective non-competitive inhibitor of hrAChE (IC50 = 0.29 M), with Ki value in nanomolar range (79 nM). Pertinent docking analysis confirmed this result, suggesting that this ligand is an interesting hit for further investigation.R.A., M.S., P.B., and K.M. were supported by European Regional Development Fund/European Social Fund (ERDF/ESF, project PharmaBrain, no. CZ.02.1.01/0.0/0.0/16_025/0007444), University of Hradec Kralove (no. SV2113-2019, VT2019-2021), and EU COST action CA15135 MuTaLig. J.M.C. thanks Ministerio de Economía (MINECO, SAF2015-65586-R) and Universidad Camilo José Cela (UCJC, grants UCJC 2020-03, and UCJC 2020-33) for support